North American Neuroendocrine Tumor Society
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 481,008 | 482,228 | −1,220 | 9.2 | 15% |
| 2012 | 610,070 | 496,230 | 113,840 | 11.7 | 15% |
| 2013 | 496,999 | 452,208 | 44,791 | 14.0 | 18% |
| 2014 | 491,559 | 450,632 | 40,927 | 15.1 | 19% |
| 2015 | 790,975 | 633,774 | 157,201 | 13.7 | 15% |
| 2016 | 851,675 | 718,136 | 133,539 | 14.3 | 13% |
| 2017 | 868,896 | 922,482 | −53,586 | 10.5 | 3% |
| 2018 | 1,016,150 | 1,120,441 | −104,291 | 7.5 | 0% |
| 2019 | 1,175,415 | 862,237 | 313,178 | 14.1 | 0% |
| 2020 | 669,754 | 367,604 | 302,150 | 42.9 | 0% |
| 2021 | 777,591 | 490,327 | 287,264 | 39.2 | 0% |
| 2022 | 1,287,018 | 1,220,534 | 66,484 | 16.4 | 0% |
| 2023 | 1,085,991 | 1,370,132 | −284,141 | 12.1 | 0% |
In its most recent public year (2023), this organization spent $284,141 more than it brought in. Its reserves stood at about 12.1 months of spending, up from 9.2 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works